Jennifer Riley
Chief Strategy Officer, Avalo Therapeutics, Inc.
Companies
- Avalo Therapeutics, Inc.Chief Strategy Officer Jan 3, 2025 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Avalo Therapeutics, Inc. AVTX37,041 shares2$428.9K at $11.58Aug 11, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 11, 2026Sold 2,655 shares at $19.59 of Avalo Therapeutics, Inc.2
- Jun 10, 2026Shares withheld for tax 588 shares at $13.10 of Avalo Therapeutics, Inc.3
- May 21, 2026Granted 34,200 shares of Avalo Therapeutics, Inc.4
- Dec 10, 2025Shares withheld for tax 637 shares at $4.10 of Avalo Therapeutics, Inc.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jun 12, 2026
- 4SEC EDGARForm 4 filed May 26, 2026
- 5SEC EDGARForm 4 filed Dec 12, 2025